The microbiota link to irritable bowel syndrome an emerging story

Gut Microbes

Volumn 3, Issue 6, 2012, Pages 572-576

  Jeffery, Ian B ^a   Quigley, Eamonn M M ^b   Öhman, Lena ^c   Simrén, Magnus ^c   O'Toole, Paul W ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Allergy; Gastroenteritis; Irritable bowel syndrome (IBS); Microbiome; Microbiota

Indexed keywords

SHORT CHAIN FATTY ACID;

ARTICLE; CLOSTRIDIALES; COHORT ANALYSIS; COLON FLORA; DEPRESSION; DIET; EUBACTERIUM; FIRMICUTES; HEREDITY; HUMAN; IMMUNE SYSTEM; IRRITABLE COLON; LACHNOSPIRACEAE; LACTOBACILLUS; LIFESTYLE; NONHUMAN; NUTRITIONAL INTOLERANCE; PREVALENCE; RUMINOCOCCACEAE;

GASTROENTERITIS; GASTROINTESTINAL TRACT; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPERSENSITIVITY; IRRITABLE BOWEL SYNDROME; METAGENOME; METAGENOMICS;

EID: 84868555218     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.21772     Document Type: Article

References (55)

1. Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 2006; 28:1726-35. discussion 1710-1. PMID:17157129; http://dx.doi.org/10.1016/j.clinthera.2006.10.010
2. Quigley EMM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012; 46:356-66. PMID:22499071; http://dx.doi.org/10.1097/ MCG.0b013e318247157c.
3. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15:3591-6. PMID:19653335; http://dx.doi.org/10.3748/wjg.15.3591
4. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EMM. Differential expression of tolllike receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2011; 106:329-36. PMID:21102570; http://dx.doi.org/10.1038/ajg.2010.438
5. Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104:404-10. PMID:19174795; http://dx.doi.org/10.1038/ajg.2008.86
6. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al.; TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364:22-32. PMID:21208106; http://dx.doi.org/10.1056/ NEJMoa1004409
7. Quigley EMM. Therapies aimed at the gut microbiota and inf lammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am 2011; 40:207-22. PMID:21333908; http://dx.doi.org/10.1016/j. gtc.2010.12.009
8. Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EMM, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61:997-1006. PMID:22180058; http://dx.doi.org/10.1136/ gutjnl-2011-301501
9. Rajilic-Stojanovic M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792-801. PMID:21820992; http://dx.doi.org/10.1053/j.gastro. 2011.07.043
10. Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156:3205-15. PMID:20705664; http://dx.doi.org/10.1099/ mic.0.043257-0
11. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7:163-73. PMID:20101257; http://dx.doi.org/10.1038/ nrgastro.2010.4
12. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 302:G1075-84. http://dx.doi. org/10.1152/ajpgi.00537.2011. PMID:22403795
13. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010; 25:252-8. PMID:20136989; http:// dx.doi.org/10.1111/j.1440-1746.2009.06149.x.
14. Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009; 15:5936-45. PMID:20014457; http://dx.doi.org/10.3748/wjg.15.5936
15. Hoskins LC, Agustines M, McKee WB, Boulding ET, Kriaris M, Niedermeyer G. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest 1985; 75:944-53. PMID:3920248; http://dx.doi.org/10.1172/JCI111795
16. Mortensen PB, Andersen JR, Arffmann S, Krag E. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 1987; 22:185-92. PMID:3033815; http://dx.doi.org/10.3109/00365528708991878
17. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996; 23:280-6. PMID:8890079; http:// dx.doi.org/10.1097/00005176-199610000-00013
18. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100:373-82. PMID:15667495; http://dx.doi. org/10.1111/j.1572-0241.2005.40312.x.
19. Valeur J, Berstad A. Colonic fermentation: a neglected topic in human physiology education. Adv Physiol Educ 2010; 34:22-22. PMID:20237231; http:// dx.doi.org/10.1152/advan.00103.2009
20. Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoAtransferase gene. Environ Microbiol 2010; 12:304-14. PMID:19807780; http://dx.doi.org/10.1111/ j.1462-2920.2009.02066.x.
21. Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson M-P, Dechelotte P, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005; 128:1996-2008. PMID:15940632; http://dx.doi.org/10.1053/j.gastro. 2005.03.082
22. Kamath PS, Phillips SF, Zinsmeister AR. Shortchain fatty acids stimulate ileal motility in humans. Gastroenterology 1988; 95:1496-502. PMID:3181675
23. Duncan SH, Louis P, Thomson JM, Flint HJ. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 2009; 11:2112-22. PMID:19397676; http://dx.doi. org/10.1111/j.1462-2920.2009.01931.x.
24. Sansonetti PJ. Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella: the yin and yang of innate immunity. Can J Infect Dis Med Microbiol 2006; 17:117-9. PMID:18418486
25. Taweechotipatr M, Iyer C, Spinler JK, Versalovic J, Tumwasorn S. Lactobacillus saerimneri and Lactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities. FEMS Microbiol Lett 2009; 293:65-72. PMID:19222575; http://dx.doi.org/10.1111/j.1574-6968.2009.01506.x.
26. van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, de Groot PJ, et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A 2009; 106:2371-6. PMID:19190178; http:// dx.doi.org/10.1073/pnas.0809919106
27. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJM, et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4562-9. PMID:20823239; http://dx.doi.org/10.1073/pnas.1000079107
28. Neville BA, Forde BM, Claesson MJ, Darby T, Coghlan A, Nally K, et al. Characterization of Pro-Inflammatory Flagellin Proteins Produced by Lactobacillus ruminis and Related Motile Lactobacilli. PLoS One 2012; 7:e40592. PMID:22808200; http://dx.doi.org/10.1371/journal.pone.0040592
29. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho A-M, Quigley EMM, et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65:263-7. PMID:18723164; http://dx.doi.org/10.1016/j.biopsych. 2008.06.026
30. Ostgaard H, Hausken T, Gundersen D, El-Salhy M. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Report 2012; 5:1382-90. PMID:22446969
31. Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol 2008; 153(Suppl 1):3-6. PMID:18721321; http://dx.doi.org/10.1111/j.1365-2249.2008.03713.x.
32. Carroccio A, Brusca I, Mansueto P, Soresi M, D'Alcamo A, Ambrosiano G, et al. Fecal assays detect hypersensitivity to cow's milk protein and gluten in adults with irritable bowel syndrome. Clin Gastroenterol Hepatol 2011; 9:965-71. e3. PMID:21839707; http://dx.doi.org/10.1016/j. cgh.2011.07.030
33. Guo H, Jiang T, Wang J, Chang Y, Guo H, Zhang W. The value of eliminating foods according to foodspecific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea. J Int Med Res 2012; 40:204-10. PMID:22429360
34. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011; 106:508-14. quiz 515. PMID:21224837; http://dx.doi.org/10.1038/ ajg.2010.487
35. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; •••: http://dx.doi.org/10.1038/ nature11319. PMID:22797518
36. Bengtson M-B, Rønning T, Vatn MH, Harris JR. Irritable bowel syndrome in twins: genes and environment. Gut 2006; 55:1754-9. PMID:17008364; http://dx.doi.org/10.1136/gut.2006.097287
37. Villani A-C, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138:1502-13. PMID:20044998; http://dx.doi. org/10.1053/j.gastro.2009.12.049
38. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136:1979-88. PMID:19457422; http://dx.doi.org/10.1053/j.gastro. 2009.02.074
39. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97:389-96. PMID:11866278
40. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4:478-85. PMID:15173836; http://dx.doi.org/10.1038/ nri1373
41. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23. PMID:19343057; http://dx.doi.org/10.1038/ nri2515
42. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 2007; 19:59-69. PMID:17118672; http:// dx.doi.org/10.1016/j.smim.2006.10.002
43. Stecher B, Chaffron S, Käppeli R, Hapfelmeier S, Freedrich S, Weber TC, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 2010; 6:e1000711. PMID:20062525; http://dx.doi.org/10.1371/journal. ppat.1000711
44. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120:4332-41. PMID:21099116; http://dx.doi. org/10.1172/JCI43918
45. Maxwell PR, Rink E, Kumar D, Mendall MA. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol 2002; 97:104-8. PMID:11808932; http://dx.doi.org/10.1111/j.1572-0241.2002.05428.x.
46. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98. PMID:19836068; http://dx.doi.org/10.1016/j. cell.2009.09.033
47. Talham GL, Jiang HQ, Bos NA, Cebra JJ. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999; 67:1992-2000. PMID:10085047
48. Schoepfer AM, Schaffer T, Seibold-Schmid B, Müller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008; 20:1110-8. PMID:18694443; http://dx.doi.org/10.1111/j.1365-2982.2008.01166.x.
49. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007; 117:3909-21. PMID:18008007
50. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5. PMID:18509436; http://dx.doi.org/10.1038/nature07008
51. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204-9. PMID:20566854; http://dx.doi. org/10.1073/pnas.0909122107
52. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41. PMID:21205640; http://dx.doi. org/10.1126/science.1198469
53. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461:1282-6. PMID:19865172; http:// dx.doi.org/10.1038/nature08530
54. Carroll IM, Ringel-Kulka T, Keku TO, Chang Y-H, Packey CD, Sartor RB, et al. Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301:G799-807. PMID:21737778; http:// dx.doi.org/10.1152/ajpgi.00154.2011
55. Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:31-9. PMID:22070725; http://dx.doi.org/10.1111/j.1365-2982.2011.01803.x.